Process for the preparation of HMG-COA reductase inhibitors
    21.
    发明授权
    Process for the preparation of HMG-COA reductase inhibitors 有权
    制备HMG-COA还原酶抑制剂的方法

    公开(公告)号:US06245535B1

    公开(公告)日:2001-06-12

    申请号:US09463912

    申请日:2000-02-02

    IPC分类号: C12P762

    CPC分类号: C12R1/07 C12P7/62 C12P17/06

    摘要: Disclosed is a process for producing a compound represented by general formula (II-a): (wherein R1 represents a hydrogen atom, a substituted or unsubstituted alkyl group, or an alkali metal; and R2 represents a substituted or unsubstituted alkyl or aryl group) [hereinafter referred to as Compound (II-a)] or the lactone form of Compound (II-a) [hereinafter referred to as Compound (II-b)] which comprises subjecting a compound represented by general formula (I-a): (wherein R1 represents a hydrogen atom, a substituted or unsubstituted alkyl group, or an alkali metal; and R2 represents a substituted or unsubstituted alkyl or aryl group) [hereinafter referred to as Compound (I-a)] or the lactone form of Compound (I-a) [hereinafter referred to as Compound (I-b)] to the action of an enzyme source derived from a microorganism belonging to the genus Bacillus and capable of converting Compound (I-a) or Compound (I-b) into Compound (II-a) or Compound (II-b) in a reaction mixture to form Compound (II-a) or Compound (II-b) in the reaction mixture, and recovering Compound (II-a) or Compound (II-b) from the reaction mixture.

    摘要翻译: 公开了一种制备由通式(II-a)表示的化合物的方法:其中R 1表示氢原子,取代或未取代的烷基或碱金属; R 2表示取代或未取代的烷基或芳基) [化学式(II-a)]或化合物(II-a)的内酯形式[以下称为化合物(II-b)]] [其中包括使通式(Ia)表示的化合物 R1表示氢原子,取代或未取代的烷基或碱金属; R2表示取代或未取代的烷基或芳基)[以下称为化合物(Ia)]或化合物(Ia)的内酯形式[ (Ia)或化合物(Ib)转化为化合物(II-a)或化合物(II-a)的酶源的作用,以下称为化合物(Ib) b)在反应混合物中形成化合物(II -a)或化合物(II-b),并从反应混合物中回收化合物(II-a)或化合物(II-b)。